A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: The rapid pace of no progress

American Journal of Gastroenterology

Volumn 102, Issue 7, 2007, Pages 1464-1473

  Modlin, Irvin M ^a   Champaneria, Manish C ^a   Chan, Anthony K C ^a   Kidd, Mark ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CONTROLLED STUDY; FEMALE; HUMAN; ILEUM TUMOR; MAJOR CLINICAL STUDY; MALE; NEGRO; NEUROENDOCRINE TUMOR; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; SEX DIFFERENCE; SMALL INTESTINE TUMOR; TREATMENT OUTCOME;

DISEASE PROGRESSION; DUODENAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ILEAL NEOPLASMS; INCIDENCE; JEJUNAL NEOPLASMS; MALE; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; PREVALENCE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION; SURVIVAL RATE; TIME FACTORS; UNITED STATES;

EID: 34250797028     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01185.x     Document Type: Article

References (41)

1. Modlin IM, Kidd M, Latich I, et al. Current status of gastrointestinal carcinoids. Gastroenterology 2005 128 : 1717 51.
2. Oberndorfer S. Karzinoide tumoren des dunndarms. Frankf Zchr Path 1907 1 : 426 30.
3. Kidd M, Modlin IM, Eick GN, et al. Isolation, functional characterization and transcriptome of mastomys ileal enterochromaffin cells. Am J Physiol Gastrointest Liver Physiol 2006 291 : G778 91.
4. Lambrecht NW, Yakubov I, Zer C, et al. The transcriptomes of purified gastric ECL and parietal cells: Identification of a novel pathway regulating acid secretion. Physiol Genomics 2006 25 : 153 65.
5. Modlin IM, Kidd M, Pfragner R, et al. The functional characterization of normal and neoplastic human enterochromaffin cells. J Clin Endocrinol Metab 2006 91 : 2340 8.
6. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003 97 : 934 59.
7. Modlin IM, Lye KD, Kidd M. A 50-year analysis of 562 gastric carcinoids: Small tumor or larger problem? Am J Gastroenterol 2004 99 : 23 32.
8. Soga J. Carcinoids of the small intestine: A statistical evaluation of 1102 cases collected from the literature. J Exp Clin Cancer Res 1997 16 : 353 63.
9. Feyrter F. Über diffuse endokrine epitheliale organe. Leipzig, Germany : J. A. Barth, 1938.
10. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission. Surveillance, Epidemiology, and End Results (SEER) Program: Public-Use, Nov 2004 Sub (1973-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission. Bethesda, MD : National Cancer Institute, 2005.
11. World Health Organization. International classification of diseases for oncology: Morphology of neoplasms, 2nd Ed. Geneva : World Health Organization, 1990.
12. United States Department of Commerce Burean of the Census. Census of population and housing: Summary population housing characteristics, PHC-1-1. Washington, DC : US Government Printing Office, 2002.
13. Van Eeden S, Quaedvlieg PF, Taal BG, et al. Classification of low-grade neuroendocrine tumors of midgut and unknown origin. Hum Pathol 2002 33 : 1126 32.
14. Johnson LA, Lavin PT, Moertel CG, et al. Carcinoids: The prognostic effect of primary site histologic type variations. J Surg Oncol 1986 33 : 81 3.
15. Soga J. Carcinoid tumors: A statistical analysis of a Japanese series of 3,126 reported and 1,180 autopsy cases. Acta Medica et Biologica 1994 42 : 87 102.
16. Godwin JD 2nd. Carcinoid tumors. An analysis of 2,837 cases. Cancer 1975 36 : 560 9.
17. Zeitels J, Naunheim K, Kaplan EL, et al. Carcinoid tumors: A 37-year experience. Arch Surg 1982 117 : 732 7.
18. Saha S, Hoda S, Godfrey R, et al. Carcinoid tumors of the gastrointestinal tract: A 44-year experience. South Med J 1989 82 : 1501 5.
19. Marshall JB, Bodnarchuk G. Carcinoid tumors of the gut. Our experience over three decades and review of the literature. J Clin Gastroenterol 1993 16 : 123 9.
20. Merrill RM, Capocaccia R, Feuer EJ, et al. Cancer prevalence estimates based on tumour registry data in the Surveillance, Epidemiology, and End Results (SEER) Program. Int J Epidemiol 2000 29 : 197 207.
21. Gamel JW, Vogel RL. Non-parametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients. Stat Methods Med Res 2001 10 : 339 52.
22. Eller R, Frazee R, Roberts J. Gastrointestinal carcinoid tumors. Am Surg 1991 57 : 434 7.
23. Gabos S, Berkel J, Band P, et al. Small bowel cancer in western Canada. Int J Epidemiol 1993 22 : 198 206.
24. DiSario JA, Burt RW, Vargas H, et al. Small bowel cancer: Epidemiological and clinical characteristics from a population-based registry. Am J Gastroenterol 1994 89 : 699 701.
25. North JH, Pack MS. Malignant tumors of the small intestine: A review of 144 cases. Am Surg 2000 66 : 46 51.
26. Cunningham JD, Aleali R, Aleali M, et al. Malignant small bowel neoplasms: Histopathologic determinants of recurrence and survival. Ann Surg 1997 225 : 300 6.
27. Maggard MA, O'Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg 2004 240 : 117 22.
28. Delvaux M, Gerard G. Capsule endoscopy in 2005: Facts and perspectives. Best Pract Res Clin Gastroenterol 2006 20 : 23 39.
29. Hemminki K, Li X. Incidence trends and risk factors of carcinoid tumors: A nationwide epidemiologic study from Sweden. Cancer 2001 92 : 2204 10.
30. Zikusoka MN, Kidd M, Eick G, et al. The molecular genetics of gastroenteropancreatic neuroendocrine tumors. Cancer 2005 104 : 2292 309.
31. Chow JS, Chen CC, Ahsan H, et al. A population-based study of the incidence of malignant small bowel tumours: SEER, 1973-1990. Int J Epidemiol 1996 25 : 722 8.
32. Haselkorn T, Whittemore AS, Lilienfeld DE. Incidence of small bowel cancer in the United States and worldwide: Geographic, temporal, and racial differences. Cancer Causes Control 2005 16 : 781 7.
33. Olney JR, Urdaneta LF, Al-Jurf AS, et al. Am Surg 1985 51 : 37 41.
34. Berge T, Linell F. Carcinoid tumours. Frequency in a defined population during a 12-year period. Acta Pathol Microbiol Scand [A] 1976 84 : 322 30.
35. Modlin IM, Shapiro MD, Kidd M. An analysis of rare carcinoid tumors: Clarifying these clinical conundrums. World J Surg 2005 29 : 92 101.
36. McGory ML, Maggard MA, Kang H, et al. Malignancies of the appendix: Beyond case series reports. Dis Colon Rectum 2005 48 : 2264 71.
37. Moyana TN, Xiang J, Senthilselvan A, et al. The spectrum of neuroendocrine differentiation among gastrointestinal carcinoids: Importance of histologic grading, MIB-1, p53, and bcl-2 immunoreactivity. Arch Pathol Lab Med 2000 124 : 570 6.
38. Solcia E, Kloppel G, Sobin LH. Histological typing of endocrine tumours. WHO international histological classification of tumours, 2nd Ed. Berlin : Springer, 2000.
39. Sokmensuer C, Gedikoglu G, Uzunalimoglu B. Importance of proliferation markers in gastrointestinal carcinoid tumors: A clinicopathologic study. Hepatogastroenterology 2001 48 : 720 3.
40. Rorstad O. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract. J Surg Oncol 2005 89 : 151 60.
41. Kidd M, Modlin IM, Mane SM, et al. The role of genetic markers-NAP1L1, MAGE-D2, and MTA1-in defining small-intestinal carcinoid neoplasia. Ann Surg Oncol 2006 13 : 253 62.